Azerbaijan National Academy of Science

The United States has ended its authorization of hydroxychloroquine and chloroquine for treating COVID-19 patients, citing reports of heart complications.

The US Food and Drug Administration (FDA) on Monday revoked its emergency authorization for two malaria drugs as potential COVID-19 treatments.

The drugs hydroxychloroquine and chloroquine — touted by President Donald Trump as a treatment for the coronavirus — are unlikely to be effective, the FDA said amid growing evidence they don't work and could cause deadly side effects.

The regulator said the drugs pose a greater risk to patients than any potential benefits.

Citing reports of heart complications, the FDA said the decades-old drugs' unproven benefits "do not outweigh the known and potential risks.''

dw.com